get a key
steadybase-$ company JYNT
account_id none on file
legal_name JOINT Corp
ticker JYNT
cik 1612630
domain thejoint.com
entry_point_account_id none on file
name The Joint Corp.
exchange Nasdaq
sector Miscellaneous
calls 2 filings 60 executives 8 family 0
why_nownone on file
calls
So kind of to answer your question, so the next steps that we're looking at is continuing to re-franchise clinics. As we do that, we'll see some pretty big reductions in big categories like salaries and wages, employee benefits, insurance. If you think about workers' comp insurance, big reduction with fewer employees. And then other things like legal fees and travel and some other expenses.

Nov 6, 2025 / receipt, needs a key / Sanjeev Razan, CEO | earnings call 2025-11-06 | transcript 11b4391a-b52f-4786-9a2a-289232adc4bf | chars 27673-28066 | segment 27

From the payroll side, from other categories like insurance and software costs and legal fees and travel. So there's quite a few line items that we're taking a look at. Being careful not to cut too soon, but to identify what the opportunity is. And then over time, tightening up with those expense line items as we continue to transition.

Aug 7, 2025 / receipt, needs a key / Nick Sherwood, other | earnings call 2025-08-07 | transcript bd97e22b-7766-4b47-9f7c-797ff46e266b | chars 26588-26926 | segment 27

filings
Minimum term commitment on plans changed from 2 to 3 months

ir_statement / Sep 16, 2026 / receipt

Rolled out enhanced pricing structure in approximately 300 clinics with the rest of the portfolio planned to begin in early Q3

ir_statement / Sep 16, 2026 / receipt

disciplined cost management

ir_statement / Sep 16, 2026 / receipt

our reiterated 2026 guidance for system-wide sales, system-wide comp sales, consolidated Adjusted EBITDA, and new franchised clinic openings

ir_statement / Sep 16, 2026 / receipt

tightening our operating structure across the system

ir_statement / Sep 16, 2026 / receipt

disciplined cost management

ir_statement / Sep 16, 2026 / receipt

our reiterated 2026 guidance for system-wide sales, system-wide comp sales, consolidated Adjusted EBITDA, and new franchised clinic openings

ir_statement / Sep 16, 2026 / receipt

tightening our operating structure across the system

ir_statement / Sep 16, 2026 / receipt

Continued focus on cost discipline across operations

ir_statement / Sep 16, 2026 / receipt

Optimizing capital allocation

ir_statement / Sep 16, 2026 / receipt

Potential entry into first international markets

ir_statement / Sep 16, 2026 / receipt

B2B partnership program

ir_statement / Sep 16, 2026 / receipt

executives
Bret Sanders director - receipt
Jake Singleton Chief Financial Officer - receipt
John P. Meloun Chief Financial Officer - receipt
Peter Holt Chief Executive Officer - receipt
Richard A. Kerley director - receipt
Sanjeev Razan CEO - receipt
Sanjeev Razdan CEO - receipt
Scott Bowman CFO - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled webcast / ir
changes
2024-10-15 President and Chief Executive Officer, appointed sec_8k
2024-10-15 President and Chief Executive Officer, departed sec_8k
2018-11-08 Chief Financial Officer, appointed sec_8k
2018-08-09 Chief Financial Officer, departed sec_8k
2018-06-21 Chief Financial Officer, departed sec_8k
2016-11-10 Chief Financial Officer, appointed sec_8k
2016-08-11 Chief Executive Officer, appointed sec_8k
2016-06-23 Chief Financial Officer, departed sec_8k
2016-05-03 Chief Operating Officer, appointed sec_8k
2015-09-18 director, appointed sec_8k
2015-04-17 director, appointed sec_8k
mcp_package_hint
steadybase-$